Journal of Affective Disorders
Volume 70, Issue 2 , Pages 191-196 , July 2002

Clinical databases of patients receiving antidepressants: The missing link between research and practice?

Received 22 May 2000 ,Revised 17 October 2000 ,Accepted 26 October 2000.

References 

  1. Alonso MP, de Abajo FJ, Martinez JJ, Montero D, Martin-Serrano G, Madurga M. Evolution of antidepressant drug consumption in Spain. The impact of selective serotonin re-uptake inhibitors. Med. Clin. (Barc.). 1998;110:557–558
  2. Arpino C, Da Cas R, Donini G, Pasquini P, Raschetti R, Traversa G. Use and misuse of antidepressant drugs in a random sample of the population of Rome. Italy. Acta Psychiatr. Scand. 1995;92:7–9
  3. Barbui C, Campomori A, D’Avanzo B, Negri E, Garattini S. Antidepressant drug use since the introduction of SSRIs: national trends, regional differences and impact on suicide rates. Soc. Psychiatry Psychiat. Epidemiol. 1999;34:152–156
  4. Baron JA, Weiderpass E. An introduction to epidemiological research with medical databases. Ann. Epidemiol. 2000;10:200–204
  5. Black N. High-quality clinical databases: breaking down barriers. Lancet. 1999;353:1205–1206
  6. Byar DP. Problems with using observational databases to compare treatments. Stat. Med. 1991;10:663–666
  7. Carné X, Arnaiz J-A. Methodological and political issues in clinical pharmacology research by the year 2000. Eur. J. Clin. Pharmacol. 2000;55:781–785
  8. Eccles M, Freemantle N, Mason J. North of England evidence-based guideline development project: summary version of guidelines for the choice of antidepressants for depression in primary care. Family Practice. 1999;16:103–111
  9. Hotopf M, Churchill R, Lewis G. The pragmatic randomised controlled trial in psychiatry. Br. J. Psychiatry. 1999;175:217–223
  10. Hotopf M, Lewis G, Normand C. Putting trials on trial – the costs and the consequences of small trials in depression: a systematic review of methodology. J. Epidemiol. Community Health. 1997;51:354–358
  11. Hylan TR, Crown WH, Meneades L, Heiligenstein JH, Melfi CA, Croghan TW, et al. SSRI antidepressant drug use patterns in the naturalistic setting: a multivariate analysis. Medical Care. 1999;37(4):AS36–44
  12. Hylan TR, Crown WH, Meneades L, Heiligenstein JH, Melfi CA, Croghan TW, et al. Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis. J Affect. Disord. 1998;47:71–79
  13. Isacsson G, Boethius G, Henriksson S, Jones JK, Bergman U. Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database. J. Affect. Disord. 1999;53:15–22
  14. Keller MB, Lavori PW. The adequacy of treating depression. J. Nerv. Mental Dis. 1988;176:471–474
  15. Kendrick T. Why can’t GPs follow guidelines on depression?. Br. Med. J. 2000;320:200–201
  16. King M. Mental health research in general practice: from head counts to outcomes. Br. J. Gen. Practice. 1998;1295–1297June
  17. Linden M, Lecrubier Y, Bellantuono C, Benkert O, Kisely S, Simon G. The prescribing of psychotropic drugs by primary care physicians: an international collaborative study. J. Clin. Psychopharmacol. 1999;19:132–140
  18. Marks I. Overcoming obstacles to routine outcome measurement. The nuts and bolts of implementing clinical audit. Br. J. Psychiatry. 1998;173:281–286
  19. Mouland G, Bratland B, Fagan M, Malde K, Rygh E, Welander F, et al. Use of new antidepressive agents in general practice. Tidsskrift for Den Norske Laegeforening. 1998;118:4497–4500
  20. Munizza C, Tibaldi F, Bollini P. Prescription pattern of antidepressants in out-patient psychiatric practice. Psychol. Med. 1995;25:771–778
  21. Nilsson L, Andersson H, Sandstrom T, Hakansson A. General practitioners prescribe more and more antidepressive agents. Repeated studies of prescriptions in a small municipality. Lakartidningen. 1998;95:2604–2606
  22. Ohayon MM, Caulet M, Priest RG, Guilleminault C. Psychotropic medication consumption patterns in the UK general population. J. Clin. Epidemiol. 1998;51:273–283
  23. Olfson M, Klerman GL. Trends in the prescription of antidepressants by office-based psychiatrists. Am. J. Psychiatry. 1993;150:571–577
  24. Olfson M, Marcus SC, Pincus HA, Zito JM, Thompson JW, Zarin DA. Antidepressant prescribing practices of outpatient psychiatrists. Arch. Gen. Psychiatry. 1998;55:310–316
  25. Ornstein S, Stuart G, Jenkins R. Depression diagnoses and antidepressant use in primary care practices. J. Family Practice. 2000;49:68–72
  26. Rosholm JU, Gram LF, Isacsson G, Hallas J, Bergman U. Changes in the pattern of antidepressant use upon the introduction of the new antidepressants: a prescription database study. Eur. J. Clin. Pharmacol. 1997;52:205–209
  27. Rouillon F, Blachier C, Dreyfus JP, Bouhassira M, Allicar MP. Pharmaco-epidemiology study of the use of antidepressant drugs in the general population. Encephale. 1996;1:39–48
  28. Sackett DL, Wennberg JE. Choosing the best research design for each question. It’s time to stop squabbling over the “best” method. Br. Med. J. 1997;315:1636
  29. Scopiglione N, Belfiglio M, Carinci F, Cavaliere D, De Curtis A, Franciosi M, et al. The effectiveness, safety and epidemiology of the use of acarbose in the treatment of patients with type II diabetes mellitus. Eur. J. Clin. Pharmacol. 1999;55:239–249
  30. Spigset O, Martensson B. Drug treatment of depression. Br. Med. J. 1999;318:1188–1191
  31. Thompson C, Kinmonth AL, Stevens L, Peveler RC, Stevens A, Ostler KJ. Effects of a clinical practice guideline and practice-based education on detection and outcome of depression in primary care: Hampshire depression project randomised controlled trial. Lancet. 2000;355:185–191

PII: S0165-0327(00)00370-0

Journal of Affective Disorders
Volume 70, Issue 2 , Pages 191-196 , July 2002

Article Tools

* Image Usage & Resolution